Aspirus St. Luke's Earns Top Performer Recognition for Influenza Immunizations

St. Luke’s announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures^® for influenza immunizations by The Joint Commission, the leading accreditor of health care organizations in the United States.

St. Luke’s was recognized as part of The Joint Commission’s 2015 annual report “America’s Hospitals: Improving Quality and Safety,” for attaining and sustaining excellence in accountability measure performance for influenza immunizations. St. Luke’s is one of 1,043 hospitals out of more than 3,300 eligible hospitals in the United States to achieve the 2014 Top Performer distinction. The Top Performer program recognizes hospitals for improving performance on evidence-based interventions that increase the chances of healthy outcomes for patients.

“Delivering the right treatment in the right way at the right time is a cornerstone of high-quality health care. I commend the efforts of St. Luke’s for their excellent performance on the use of evidence-based interventions,” said Mark R. Chassin, MD, FACP, MPP, MPH, president and CEO, The Joint Commission.

“We understand what matters most to patients at St. Luke’s is the quality and safety of the care they receive. That is why we have made it a top priority to improve positive patient outcomes through evidence-based care processes,” said John Strange, St. Luke’s President/CEO. “St. Luke’s is proud to be named a Top Performer for influenza immunizations as it recognizes the knowledge, teamwork and dedication of our entire hospital staff.”